The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia

被引：4
作者：
Ding, Zhi-Chun [1 ]
机构：
[1] Augusta Univ, Georgia Canc Ctr, Canc Immunol Immunotherapy & Tolerance Program, 1120 15th St,CN4144B, Augusta, GA 30912 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2018年 / 6卷 / 11期
关键词：
CANCER REGRESSION; METASTATIC MELANOMA; IMMUNOTHERAPY; LYMPHOCYTES; THERAPY; GENE; CYCLOPHOSPHAMIDE; PERSISTENCE; EXPRESSION; RESPONSES;
D O I：
10.21037/atm.2018.05.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 24 条
  • [1] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
    Brentjens, Renier J.
    Davila, Marco L.
    Riviere, Isabelle
    Park, Jae
    Wang, Xiuyan
    Cowell, Lindsay G.
    Bartido, Shirley
    Stefanski, Jolanta
    Taylor, Clare
    Olszewska, Malgorzata
    Borquez-Ojeda, Oriana
    Qu, Jinrong
    Wasielewska, Teresa
    He, Qing
    Bernal, Yvette
    Rijo, Ivelise V.
    Hedvat, Cyrus
    Kobos, Rachel
    Curran, Kevin
    Steinherz, Peter
    Jurcic, Joseph
    Rosenblat, Todd
    Maslak, Peter
    Frattini, Mark
    Sadelain, Michel
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)
  • [2] Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Brentjens, Renier J.
    Riviere, Isabelle
    Park, Jae H.
    Davila, Marco L.
    Wang, Xiuyan
    Stefanski, Jolanta
    Taylor, Clare
    Yeh, Raymond
    Bartido, Shirley
    Borquez-Ojeda, Oriana
    Olszewska, Malgorzata
    Bernal, Yvette
    Pegram, Hollie
    Przybylowski, Mark
    Hollyman, Daniel
    Usachenko, Yelena
    Pirraglia, Domenick
    Hosey, James
    Santos, Elmer
    Halton, Elizabeth
    Maslak, Peter
    Scheinberg, David
    Jurcic, Joseph
    Heaney, Mark
    Heller, Glenn
    Frattini, Mark
    Sadelain, Michel
    [J]. BLOOD, 2011, 118 (18) : 4817 - 4828
  • [3] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
    Cartellieri, Marc
    Bachmann, Michael
    Feldmann, Anja
    Bippes, Claudia
    Stamova, Slava
    Wehner, Rebekka
    Temme, Achim
    Schmitz, Marc
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [4] Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
    Davila, Marco L.
    Riviere, Isabelle
    Wang, Xiuyan
    Bartido, Shirley
    Park, Jae
    Curran, Kevin
    Chung, Stephen S.
    Stefanski, Jolanta
    Borquez-Ojeda, Oriana
    Olszewska, Malgorzata
    Qu, Jinrong
    Wasielewska, Teresa
    He, Qing
    Fink, Mitsu
    Shinglot, Himaly
    Youssif, Maher
    Satter, Mark
    Wang, Yongzeng
    Hosey, James
    Quintanilla, Hilda
    Halton, Elizabeth
    Bernal, Yvette
    Bouhassira, Diana C. G.
    Arcila, Maria E.
    Gonen, Mithat
    Roboz, Gail J.
    Maslak, Peter
    Douer, Dan
    Frattini, Mark G.
    Giralt, Sergio
    Sadelain, Michel
    Brentjens, Renier
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
  • [5] Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514
  • [6] EXPRESSION OF IMMUNOGLOBULIN-T-CELL RECEPTOR CHIMERIC MOLECULES AS FUNCTIONAL RECEPTORS WITH ANTIBODY-TYPE SPECIFICITY
    GROSS, G
    WAKS, T
    ESHHAR, Z
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 10024 - 10028
  • [7] Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
    Grupp, Stephan A.
    Kalos, Michael
    Barrett, David
    Aplenc, Richard
    Porter, David L.
    Rheingold, Susan R.
    Teachey, David T.
    Chew, Anne
    Hauck, Bernd
    Wright, J. Fraser
    Milone, Michael C.
    Levine, Bruce L.
    June, Carl H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (16) : 1509 - 1518
  • [8] Analysis of Drug Development Paradigms for Immune Checkpoint Inhibitors
    Jardim, Denis L.
    Gagliato, Debora de Melo
    Giles, Francis J.
    Kurzrock, Razelle
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (08) : 1785 - 1794
  • [9] Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
    Johnson, Laura A.
    Morgan, Richard A.
    Dudley, Mark E.
    Cassard, Lydie
    Yang, James C.
    Hughes, Marybeth S.
    Kammula, Udai S.
    Royal, Richard E.
    Sherry, Richard M.
    Wunderlich, John R.
    Lee, Chyi-Chia R.
    Restifo, Nicholas P.
    Schwarz, Susan L.
    Cogdill, Alexandria P.
    Bishop, Rachel J.
    Kim, Hung
    Brewer, Carmen C.
    Rudy, Susan F.
    VanWaes, Carter
    Davis, Jeremy L.
    Mathur, Aarti
    Ripley, Robert T.
    Nathan, Debbie A.
    Laurencot, Carolyn M.
    Rosenberg, Steven A.
    [J]. BLOOD, 2009, 114 (03) : 535 - 546
  • [10] Gene-engineered T cells for cancer therapy
    Kershaw, Michael H.
    Westwood, Jennifer A.
    Darcy, Phillip K.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (08) : 525 - 541
123